Enjoy complimentary customisation on priority with our Enterprise License!
According to the Technavio’s analyst, the global hybrid imaging market is anticipated to grow at a steady rate and will post a CAGR of more than 8% during the forecast period. The growing adoption of positron emission tomography (PET) or computed tomography (CT) hybrid imaging will drive the growth prospects for the global hybrid imaging market until the end of 2021. The PET-CT represents one of the medical imaging modalities, which is used for early diagnosis, accurate disease staging, and acts as an effective response to the treatment of chronic conditions such as cancer. Also, new technological advancements in this hybrid imaging modality such as precise measurement for better differentiation and measurement of tumors increased data storage capabilities for oncologists to track tumor developments, and less patient movement will result in the market’s growth.
In terms of geography, the Americas accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. One of the major factors responsible for the increasing demand for hybrid imaging modalities in this region is the availability of favorable reimbursement facilities by Centers for Medicare and Medicaid Services (CMS).
The global hybrid imaging market is highly competitive and diversified due to the presence of a large number of regional and international vendors across the globe. These vendors are increasingly competing against each other based on factors such as aggressive pricing, product differentiation, capital support for product or technology up gradation, remote monitoring services, convenient to use, and distribution partnerships.
Key vendors in this market are -
Other prominent vendors in the market include Advanced Accelerator Applications, AGFA Healthcare, BC Technical, Cardinal Health, Carestream Health, CMR Naviscan, Cubresa, Eczacibasi-Monrol Nuclear Products, FUJIFILM Holdings, IBA Molecular, Mylin Medical, CMR Naviscan, Nordion, Photo Diagnostic Systems, Piramal Imaging, Positron, RadioMedix, Roses Medical & Surgical Supply, Sofie Biosciences, and Toshiba Medical Systems.
The PET-CT segment accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. Some of the factors responsible for the market segment’s growth includes technological advancements, decreasing prices, increasing awareness among end-users, and availability of reimbursements.
The oncology segment is one of the fastest growing segments of the market and will continue to grow for the next four years. One of the major factors responsible for the market segment’s growth is the increasing use of hybrid images in the oncological segment to understand and detect location molecules in the body as tracer decays.
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by product type
PART 07: Market segmentation by application
PART 08: Geographical segmentation
PART 09: Market drivers
PART 10: Impact of drivers
PART 11: Market challenges
PART 12: Impact of drivers and challenges
PART 13: Market trends
PART 14: Vendor landscape
PART 15: Key vendor analysis
PART 16: Appendix
PART 17: Explore Technavio
Tags: diagnostic ultrasound, digital mammography, medical imaging, advanced medical imaging, medical imaging industry outlook, medical devices market study,
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.